Skip to main content
. 2021 Jul 21;11:703233. doi: 10.3389/fonc.2021.703233

Figure 1.

Figure 1

(A) Treatment response to lenalidomide-based treatment and subsequent lines of therapy. (B) Progression free survival for lenalidomide-based therapy (T0) and each subsequent line (T1, T2, T3 etc.).